13F Notebook
← Dashboard
Fund detail

Viking Global Investors (Halvorsen)

hedge-fund, active

Quarters 52
2025-03-31 $31.48B
Positions 91
Showing 9 of 9 rows (filtered from 113)

Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.

# Issuer Value ↓ Weight Shares Share Δ Share Δ % Prev Weight First Held Price Est. Cost Unrealized % Status
1 API GROUP CORP APG $770.2M 2.45% 21,537,518 +0 +0.00% 2.51% 2020-06-30 $36 ~$12 +188.51%
2 ADAPTIVE BIOTECHNOLOGIES COR ADPT $222.9M 0.71% 29,993,708 +0 +0.00% 0.58% 2019-06-30 $7 ~$48 -84.62%
3 NEWAMSTERDAM PHARMA COMPANY $142.9M 0.45% 6,978,534 +0 +0.00% 0.58% 2022-12-31 $20 ~$11 +81.86%
4 STANDARD BIOTOOLS INC LAB $63.3M 0.20% 58,651,170 +0 +0.00% 0.33% 2024-03-31 $1 ~$3 -60.15%
5 PHARVARIS N V $57.4M 0.18% 3,653,310 +0 +0.00% 0.23% 2021-03-31 $16 ~$24 -33.54%
6 INHIBRX BIOSCIENCES INC INBX $25.0M 0.08% 1,787,705 +0 +0.00% 0.09% 2024-06-30 $14 ~$14 -1.27%
7 GINKGO BIOWORKS HOLDINGS INC DNA $20.4M 0.06% 3,577,128 +0 +0.00% 0.11% 2024-09-30 $6 ~$8 -30.06%
8 RALLYBIO CORP $2.7M 0.01% 4,194,777 +0 +0.00% 0.01% 2021-09-30 $1 ~$18 -96.28%
9 PEPGEN INC PEPG $2.1M 0.01% 1,482,434 +0 +0.00% 0.02% 2022-06-30 $1 ~$10 -85.85%